High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial
Jean‐Paul Fermand(Sorbonne Université), Jean‐Claude Brouet(Centre National de la Recherche Scientifique), Catherine Boccacio(Hôpital Cochin), Philippe Ravaud(Inserm), Xavier Mariette(Inserm), Sylvie Chevret(Saint Louis University Hospital), Édouard Pertuiset(Centre Hospitalier René-Dubos), Margaret Macro(Hôpital Cochin), Coralie Bélanger(Hôpital Cochin), Véronique Leblond(Sorbonne Université), François Dreyfus(Université Paris-Sud), Marine Diviné(Hôpital Cochin)
Cited by 50
Related Papers
Biologic and clinical significance of cryoglobulins
|The American Journal of Medicine|1974|1.7k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726